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Short Title: Adiposity & bone health 
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Abstract 
Background: The relationship between bone health and adiposity and how it may be 
affected in people with chronic metabolic conditions is complex.  
Methods: 17 women with Type 1 diabetes mellitus (T1DM) and 9 age-matched healthy 
women with a median age of 22.6 yrs (range, 17.4, 23.8) were studied by 3T-MRI and MR 
spectroscopy to assess abdominal adiposity, tibial bone microarchitecture and vertebral 
bone marrow adiposity. Additional measures included DXA-based assessments of total body 
(TB), femoral neck (FN) and lumbar spine (LS) bone mineral density (BMD) and fat mass 
(FM). 
Results: Although women with T1DM had similar BMI and bone marrow adiposity to the 
controls, they had higher visceral and subcutaneous adiposity on MRI (p<0.05) and total 
body FM by DXA (p=0.03). Overall, in the whole cohort, a clear inverse association was 
evident between bone marrow adiposity and BMD at all sites (p<0.05). These associations 
remained significant after adjusting for age, BMI, FM, and abdominal adiposity. In addition, 
visceral adiposity, but not subcutaneous adiposity, showed a positive association with bone 
marrow adiposity (r,0.4, p=0.03), and a negative association with total body BMD (r,0.5, 
p=0.02). Apparent trabecular separation as assessed by MRI showed an inverse association 
to total body BMD by DXA (r,–0.4, p=0.04).  
Conclusion:  Irrespective of the presence of an underlying metabolic condition, young 
women display a negative relationship between MRI-measured bone marrow adiposity and 
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DXA-based assessment of bone mineral density. Furthermore, an association between bone 
marrow adiposity and visceral adiposity supports the notion of a common origin of these two 
fat depots.  
 
Background 
Type 1 diabetes mellitus (T1DM) is a chronic metabolic disorder that is often associated with 
an alteration in the quantity and distribution of adipose tissue (1). In addition, people of all 
ages with T1DM are at a higher risk of fractures (2-4). Although the underlying 
pathophysiology of diabetic osteopathy is complex and multifactorial (5), there is a growing 
body of evidence that suggests that the interplay between fat and bone may generally play 
an important role in conferring skeletal fragility (6). Previous studies have reported an 
inverse association of bone marrow adiposity (BMA) with bone mineral density (BMD) in 
elderly people with osteoporosis and other metabolic conditions (7, 8). Several clinical and 
experimental studies indicate that adipose tissue itself is not functionally uniform, and 
different adipose depots have distinctive characteristics including adipocytokine production 
(9) with visceral adipose tissue (VAT) playing an important role in the maintence of bone 
health (10, 11). Thorough, in vivo assessment of adiposity at multiple sites, including 
abdominal, total body and bone marrow, requires several methods of imaging and hitherto 
this has rarely been performed in humans (11). There is an increasing realisation that a 
comprehensive assessment of bone requires an assessment of bone microarchitecture as 
well as bone densitometry (13). Metabolic conditions that may affect bone health, such as 
diabetes, are also associated with marked alterations in body composition, adiposity and 
bone marrow adiposity (12). Our objective was to utilise a wide range of imaging tools to 
evaluate adiposity at several sites and assess its relationship to quantifiable, imaging–based 
markers of bone health in young women with and without T1DM. The underlying hypothesis 
was that the inverse association between adiposity and bone health exists irrespective of the 
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body compartment and mode of assessment of bone health.  By performing a multimodality 
assessment of bone health and adiposity this study has also provided greater mechanistic 
insights into the link between bone and fat as well as the pathophysiology of diabetic 
osteopathy. 
 
Methods 
Population 
Between January and July 2014, 9 healthy women and 17 women with T1DM between the 
ages of 17 and 34 years participated in a study of bone health and adiposity. Exclusion 
criteria included the presence of metallic implants and pacemakers, active or planned 
pregnancy or lactation, kidney disease, chronic use of drugs that are known to affect bone 
health and other chronic diseases that are known to be associated with an increased risk of 
fractures. Information on personal health and lifestyle habits, including cigarette smoking, 
alcohol consumption, current medication, use of vitamins or calcium, age at menarche, use 
of oral contraceptives, hours of weight-bearing physical activity per week, history of fractures 
and a family history of early osteoporosis was also collected. In the women with T1DM, 
information on age of diagnosis, disease duration, insulin therapy and presence of 
microvascular complications was obtained from the case records. The study protocol was 
approved by the national research ethics service and all participants provided written 
informed consent. 
MicroMRI 
MRI images of the proximal tibia with a resolution of 0.3mm x 0.3mm x 0.3mm were 
acquired with a 3T MRI scanner (Siemens Verio, Erlangen Germany) using a 
transmit/receive extremity coil which was suitable for knee imaging. The method used has 
been described previously (1, 13) but briefly, the images were acquired from the right 
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proximal tibia using the epiphyseal growth plate as a reference, with the first slice positioned 
immediately distal and parallel to the growth plate and subsequent slices positioned distally 
along the tibia. The pulse sequence was a fully balanced steady state free precession 
(bSSFP), and the acquisition was 3D. Standardized analysis was performed using the slice 
that was located at the insertion point of the patellar ligament. The images were coded and 
analysed blindly using software written in IDL (Research Systems Inc, Boulder, CO) to 
obtain measures for apparent bone volume to total volume ratio (appBV/TV), apparent 
trabecular number (appTbN), apparent trabecular thickness (appTbTh) and apparent 
trabecular separation (appTbSp). Validation of the software was performed using a custom-
made phantom as described previously (13).  
 
MR Spectroscopy (MRS) 
1H-MRS was performed using a 6-channel body array (anterior) and a 12-channel spine coil 
(posterior).  Spectra were obtained from a 20mm x 20mm x 20mm volume within the 
vertebral body of L3, using a method which has been described previously (1, 13). A PRESS 
sequence with no water suppression was used with the following parameters:  TR = 
2000ms, TE = 30ms, no. of averages = 80, total scan time = 4 minutes.  Analysis was 
performed following fitting of the spectrum in the time domain using a nonlinear least-
squares algorithm, AMARES (14) in the Java-based magnetic resonance user interface 
(jMRUI) software package (15). The area under the water peak and lipid peak were obtained 
and used to calculate the lipid to water ratio (LWR) and percentage fat fraction (%FF) as a 
measure of bone marrow adiposity (BMA) (16) using the following equation: 
100
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Of the participants who had MRS scans, approval was also obtained to simultaneously 
assess abdominal fat using the 6-channel body array and the 12-channel spine coil. A T1 
weighted turbo-spin-echo sequence was used to acquire 5 axial slices at the level of L3 with 
a 4 mm slice thickness using the following parameters: (TR) Repetition Time 300ms,  (TE) 
Echo Time 11ms, (TA) Acquisition Time 17.2s, matrix size=288x320, with 255×340 mm field 
of view. The images were analysed with Slice-O-matic™ (version 4.3, Tomovision, Canada) 
for semi-automatic measurement of cross-sectional area (CSA), subcutaneous adipose 
tissue, (SAT), visceral adipose tissue (VAT) and total adipose tissue (TAT) (Fig. 1).  
 
Dual Energy X-ray Absorptiometry (DXA) 
DXA of the total body (TB), lumbar spine at L2-L4 (LS) and femoral neck (FN) was 
performed by a Lunar Prodigy Scanner (GE Medical Systems, Waukesha, Wisconsin, USA). 
Outputs included bone area (cm2), BMC (g) and mean areal BMD (g/cm2) and these data 
were used to calculate standard deviation scores (SDS) of  TB, LS and FN BMD and LS 
bone mineral apparent density (BMAD) (17). DXA was also used to measure fat mass and 
these data were used to calculate percentage FM and FM SDS to correct for age and sex. 
 
Statistical Analysis 
Data analysis was performed using Minitab 17, Minitab Inc, State College, PA.  All data were 
described as medians and ranges; comparison between the cases of T1DM and healthy 
women was performed by the Mann-Whitney U test for continuous variables and by the Chi 
Squared test for categorical variables. Spearman correlation analysis was used to assess 
the univariate relationship between continuous variables and statistical significance was set 
at p<0.05. Multivariable linear regression was performed to examine associations of 
vertebral BMA, BMD and visceral adiposity. BMA, age, height, weight, and VAT were 
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selected for the regression model because of their close correlation to BMD. Multivariate 
standard least squares regression modeling was performed to control for age, BMI, BMD, 
and VAT. 
 
Results 
Study Participants 
There were no significant demographic or anthropometric differences between the cases 
and controls (Table 1). The median age of the 17 women with T1DM was 23.7 yrs (17.4, 34), 
and the median age at diagnosis was 10.1 yrs (4.8, 14.8) with a median duration of diabetes 
of 13.6 yrs (6.8, 26.5). In the T1DM cohort, 5 (29%) reported a history of traumatic fractures 
and in 3, the fractures had occurred before the diagnosis of diabetes. No fractures were 
reported in the healthy women group and none of the participants were on routine vitamin 
supplementation. Of the 17 cases, 9 (50%) had retinopathy of which 8 had background 
retinopathy alone, 2 (7%) were being treated for hypertension, and 3 (18%) had 
microalbuminuria. One of the cases had stable Crohn’s disease over the study period 
requiring only sulfasalazine therapy for three years prior to the baseline assessment. At the 
time of the study the women with T1DM were on a median insulin dose of 2.5 IU/kg/d (1.2, 
3.7) and the median HbA1c was 75 mmol/mol (51,118). 
 
Measures of Adiposity 
Abdominal adiposity parameters measured by MRI and including CSA, SCAT, VAT and 
TAT, were higher in the T1DM cases compared to the healthy women (Table 2). 
Additionally, women with T1DM had higher DXA-measured TB FM SDS (p=0.03). However, 
median vertebral BMA as assessed by measuring percentage fat fraction at L3 was similar 
in the two groups of women. VAT was positively associated with increasing vertebral BMA 
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FF (%) for all participants (0.42, 0.03), although when the participants were sub-divided into 
healthy women and those with T1DM the association remained for the healthy women (0.72, 
0.02) but not for those with T1DM (0.31, 0.22).  However other abdominal measures of 
SCAT and TAT did not show an association with vertebral BMA FF (%) (Suppl Table I).  
 
Measures of Bone Mineral Status & Microarchitecture 
No significant difference in DXA or MRI-based parameters was evident between women with 
or without T1DM (Table 2). In the whole cohort of participants, body weight showed a clear 
association to DXA-BMD but not to MRI-measured bone microarchitecture (Fig.2). On the 
other hand, age showed a clear association to appTbN and appTbSp but not BMD over the 
age range studied (r, -0.61, p=0.001 and r, 0.45, p=0.02, respectively) and the extent of this 
association was not influenced by the coexistence of DM (Fig.3). On assessing the 
association between age and appTbN for the cases and controls separately the association 
remained significant for the former (r, -0.5, p=0.04 and r, -0.54, p=0.09. repectively) (Fig. 3). 
Although the association between DXA measured TB-BMD, FN-BMD and LS-BMD was 
strong as expected, the association of these DXA parameters with MRI-based 
microarchitectural parameters was weak and not significant (Supplementary Table II). 
 
Correlation between Markers of Adiposity & Bone Mineral Status & Microarchitecture 
MRI-based markers of bone microarchitecture did not show any significant association to 
vertebral BMA.  However, vertebral BMA showed a negative association to several 
measures of DXA-based markers of bone mineral status including TB-BMD (r, -0.54, 
p=0.005), LS-BMD (r, -0.40, p=0.04) and FN-BMD (r, -0.44, p=0.03) (Table 3). Vertebral 
BMA was a significant determinant of BMD (p<0.05) in all models when its relationship was 
assessed in a regression model with age, BMI, VBMA, TAT, VAT. Amongst the MRI-based 
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markers of abdominal adiposity and DXA-based markers of bone mineral status, VAT and 
TB-BMD SDS were the sole parameters which showed a clear association (r,-0.46, p=0.02) 
and this association did not seem to be dependent on whether the subject had diabetes or 
not (Fig. 4). Given that there is an association between VAT and TB- BMD SDS as well as 
VAT and vertebral BMA, adjustment for VAT was performed by multivariate analysis and an 
association between vertebral BMA and TB-BMD was still evident (p=0.04). 
 
Discussion 
To our knowledge, this is the first study to characterize relationships between measures of 
adiposity with DXA and MRI-based measures of bone parameters in young women. The 
study was limited by its small size. However, by including a group of women with T1DM 
within our study cohort, we were also able to explore relationships over a wider range of 
adiposity.   
 
Since osteoblasts and adipocytes share the bone marrow derived mesenchymal stem cells 
(MSC) as a common precursor (18, 19), it is hypothesized that an increase in adipogenesis 
may impair bone integrity through reducing osteoblastogenesis (19). The study clearly 
showed that VAT and BMA are negative predictors of BMD. The inverse relationship 
between DXA-based measures of bone parameters at multiple skeletal sites and bone 
marrow adiposity has been reported in a range of people across the age span as well as 
those with anorexia nervosa, on glucocorticoid therapy and other osteoporotic conditions 
(20-22). Rodent models of acute T1DM are also associated with higher BMA (23) and 
although stable T1DM may not be associated with raised BMA (1), in people with diabetes, 
BMA may be inversely related to BMD (24). The current findings provide additional support 
for this inverse relationship and also confirm that this relationship is found in health and 
disease. Whilst it is plausible that these relationships may be altered in people with diabetes, 
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the current study did not show that the relationship, itself is altered. It is possible, however, 
that this relationship may vary from one pathological condition to another (13) and this 
requires further exploration. Recent studies also suggest that unsaturated bone marrow 
lipids may be more strongly associated than overall bone marrow adiposity with fragility 
fractures in diabetes (8, 25) and there is a need to explore this further.  
 
In the present study, we observed an inverse relationship between BMA and BMD in non-
anatomically-matched regions such as the spine for BMA and femoral and total body for 
BMD, as well as in anatomically-matched region such as the spine. Therefore, it is 
reasonable to assume that both MSC differentiation at a local level and hormonal factors at 
a systemic level contribute to the observed inverse relationship between BMA and BMD. 
These observations will be further  
 
strengthened by an assessment of bone microarchitecture and BMA at other skeletal sites in 
the future. MRI with its ability to study microarchitecture as well as BMA promises to be a 
useful imaging modality for studying these relationships in larger cohorts. A thorough 
investigation of adiposity and bone health as performed by us may, therefore, be vital when 
new therapies that treat osteoporosis at both the MSC level and systemic level are explored.   
 
The role of VAT in influencing bone development has not been clearly elucidated; previous 
studies have shown an inconsistent association between body fat and bone measures(26-
32). These studies were limited by the use of DXA, which in the past has been unable to 
distinguish VAT from SAT. In our study, despite a high level of correlation between the DXA 
and MRI-based parameters of adiposity, we found differences in their relationship to BMA 
and the bone parameters. Our data are consistent with other reports (31, 33) that did not 
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show any association between adiposity, as assessed by DXA, and BMD. In contrast, other 
studies have reported that visceral fat may have a negative association with bone mineral 
status and correlates inversely with BMD and bone structure (10, 34, 35). However, in our 
study we did not find this association with bone microarchitecture. Consistent with our 
findings, Bredella et al. (10) also concluded that both BMA and VAT may have a detrimental 
effect on BMD.  
 
Recent studies including the current study have (36) reported a deficit in bone 
microarchitecture, as assessed by MRI, in people with T1DM and especially those who have 
some evidence of a vasculopathy (1, 36). In contrast, such a consistent abnormality in DXA-
based bone parameters in T1DM is rarely described (5). A discrepancy between DXA and 
an assessment of trabecular bone microarchitecture as reported in the current study, 
reinforces the point that the two modalities, MRI and DXA, may not necessarily provide the 
same information about bone health but may complement each other. Whilst, there are other 
techniques such as high resolution pQCT which can also provide information on 
microarchitecture at specific sites, MRI has the added advantage of being able to assess 
bone marrow adiposity . 
 
In summary, visceral adipose tissue and bone marrow adiposity are closely linked to each 
other and show a negative association to BMD in young women with diabetes as well as 
healthy women. A comprehensive assessment of bone health may require an approach that 
combines conventional assessment by DXA with an assessment of bone marrow adiposity 
and microarchitecture by MRI.   
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Legend 
 
Fig 1. Representative MR Image through axial slice of abdomen at L3 vertebrae showing 
T1-weighted images with subcutaneous adipose tissue (SAT) and visceral adipose tissue 
(VAT) in a woman with Type 1 Diabetes (A) and in a healthy woman (B). 
 
Fig 2.   The relationship between vertebral bone marrow adiposity expressed as fat fraction 
(FF %) as assessed by MRS and abdominal adipose tissue as assessed by MRI. Cross 
sectional area (CSA) (A),  subcutaneous adipose tissue  (SCAT) (B), visceral adipose tissue  
(VAT) (C) and total adipose tissue (TAT) (D) in women with Type 1 Diabetes (filled circles, 
solid regression line) and in healthy women (open circles, broken regression line). The 
correlation (r) and its p-value (p) are for the combined group of women. 
  
Fig 3.    The relationship between parameters of bone health as assessed by MRI and DXA 
and age or body weight in women with Type 1 Diabetes (filled circles, solid regression line) 
and in healthy women (open circles, broken regression line). The relationship of MRI-based 
apparent trabecular number (TbN) with age (A) and body weight (B) and the relationship of 
DXA-based total body bone mineral density (TB-BMD) with age (C) and body weight (D). 
Regression lines have been added to each plot, solid line for the cases and the broken line 
for the controls. The correlation (r) and its p-value (p) are for the combined group of women. 
 
Fig 4.   The relationship between visceral adipose tissue (VAT) as assessed by MRI and TB-
BMD SDS in women with Type 1 Diabetes (filled circles, solid regression line) and in healthy 
women (open circles, broken regression line). The correlation (r) and its p-value (p) are for 
the combined group of women. 
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  Type 1 Diabetes Mellitus (n,17) 
 
Healthy Women (n, 9) p 
Age (years)                                                                                                                                                                             23.7
(17.4, 34) 
 
21.6  
(20, 23.8) 
0.1 
Ht (cm) 163.6 
(160.5,175.5) 
 
166.2 
(159.2,183) 
0.5 
Ht SDS -0.03  
(-1.5, 1.9) 
 
0.4  
(-0.7, 3.2) 
0.5 
Wt (kg) 68.8  
(50.2,91.5) 
 
63.8  
(54.4,76.5) 
0.5 
Wt SDS 1.2  
(-1, 2.9) 
 
0.7  
(-0.4 , 2.9) 
0.5 
BMI  24.4  
(18.7, 31.6) 
 
22.6  
(19.6, 28.0) 
0.1 
BMI SDS 0.82  
(-1.4, 2.4) 
 
0.2  
(-0.9, 1.7) 
0.1 
Cigarette smoker (n) 4 
 
0 0.2 
Regular alcohol consumption (n)  13 
 
7 1 
Age at Menarche (years) 13  
(10, 17.50) 
 
12  
(11, 15) 
0.9 
Previous pregnancy (n) 3 
 
0 0.2 
Oral contraceptive use (n) 10 
 
9 0.4 
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Table 1. Clinical characteristic of study participants. 
 
 
 
 Type 1 Diabetes Mellitus 
(n, 17 ) 
Healthy Women 
 (n, 9) 
p 
MRI - Abdominal adiposity 
CSA (mm
3
) 
SCAT(mm
3
) 
VAT(mm
3
) 
TAT(mm
3
) 
 
51829 (31807, 73485) 
22662 (8747, 38179) 
6085 (2112, 11373) 
28274 (14727, 49161) 
 
39761(32004, 55860) 
12529 (8078, 25829) 
3460 (1864, 7134) 
16251 (10343, 32963) 
 
 
0.04 
0.02 
0.004 
0.007 
DXA - Fat Mass 
TB-FM (kg) 
TB-fat mass SDS  
 
24.47(14.30,41.53) 
1.1 (0.5, 2.5) 
 
17.56(14.01,31.76) 
0.3 (-0.2,1.9) 
 
0.07 
0.03 
Physical activity (hrs/wk) 3  
(0, 10) 
3  
(1.5, 10 ) 
 
0.8 
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MRS - Bone Marrow Adiposity 
L3 fat fraction (%) 
 
26.9 (17.2, 58.5) 
 
25.2 (8.3, 35.1) 
 
0.5 
MRI - Bone microarchitecture  
App BV/TV 
App TbN  (mm-1) 
App TbSp (mm) 
App ThTh (mm) 
 
DXA – Bone Mineral Density 
 
0.29 (0.25, 0.38) 
0.26 (0.20, 0.32) 
2.65 (2.06, 3.38) 
1.17 (0.95, 1.46) 
 
0.32 (0.27, 0.42) 
0.27 (0.24, 0.31) 
2.52 (1.94, 2.79) 
1.19 (1.00, 1.52) 
 
0.1 
0.2 
0.08 
0.7 
TB BMC (g)  
TB BMD (g/cm2) 
TB BMD SDS 
 
2504 (1669, 2967) 
1.1 (1, 1.2) 
-0.2 (-1.1, 1.5) 
2636 (2147, 3) 
1.1 (1, 1.3) 
0.4 (-1.2, 2.0) 
0.3 
0.5 
0.3 
LS BMC (g) 
LS BMD (g/cm2)  
LS BMD SDS 
49.8 (26.6, 60.8) 
1.18 (0.82, 1.39) 
-0.1 (-3.1, 1.6) 
56.7 (38.2, 66.9) 
1.24 (0.99, 1.42) 
0.4 (-1.7, 1.8) 
0.2 
0.8 
0.8 
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LS BMAD 
 
0.38 (0.29, 0.42) 0.37 (0.27, 0.46) 0.7 
FN BMC (g) 
FN BMD (g/cm2)  
FN BMD SDS 
 
28.2 (21.3, 34.1) 
0.94 (0.84, 1.13) 
-0.6 (-1.2, 1) 
31.1 (24.2, 35.8) 
0.98 (0.88, 1.22) 
-0.2 (-1.2, 1.7) 
0.2 
0.6 
0.3 
 
Table 2. Markers of adiposity and bone health as assessed by micro MRI, DXA and MRS in women with T1DM and in health women. 
CSA- cross-sectional area of adipose tissue; SCAT – subcutaneous adipose tissue; VAT- visceral adipose tissue; TAT – total adipose tissue; 
TB FM- total body fat mass; TB BMC; total body bone mineral content; TB BMD; total body bone mineral density; LS BMC- lumbar spine bone 
mineral content; LS BMD- lumbar spine bone mineral density; LS BMAD- lumbar spine bone mineral apparent  density; FN-BMC; femoral neck 
bone mineral content; FN-BMD; femoral neck bone mineral density; AppBV/TV – apparent bone volume/total volume; AppTb.N – apparent 
trabecular number; AppTbSp – apparent trabecular separation; AppTbTh – apparent trabecular thickness; BMA– bone marrow adiposity; FF% -
fat fraction.  
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Markers of Adiposity CSA SCAT VAT TAT TB FM TB FM SDS Vertebral BMA 
Markers of Bone 
 
TB BMD (g/cm2) 
TB BMD SDS 
TB BMC (g)  
 
  
 
0.02, p=0.9 
-0.21, p=0.3 
 0.11, p=0.6 
 
 
-0.05, p=0.8 
-0.26, p=0.2 
-0.05, P=0.8 
 
 
-0.18, p=0.4 
   -0.46, p=0.02 
-0.18, p=0.4 
 
 
-0.14, p=0.5 
-0.38, p=0.1 
-0.12, p=0.6 
  
 
0.06, p=0.8 
-0.18, p=0.4 
 0.21, p=0.3 
  
 
0.01, p=0.6 
-0.20, p=0.4 
 0.19, p=0.4 
   
 
  -0.54, p=0.005 
  0.49, p=0.013 
   -0.28, p=0.2 
LS BMD (g/cm2)  
LS BMD SDS 
LS BMC (g) 
LS BMAD 
 
 0.14, p=0.5 
 0.11, p=0.6 
-0.01, p=1.0 
 0.25, p=0.2 
 0.08, p=0.7 
 0.06, p=0.8 
-0.11, p=0.6 
 0.19, p=0.3 
0.04, p=0.8 
0.02, p=0.9 
-0.12, p =0.5 
0.20, p=0.3 
 0.00, p=0.9 
-0.02, p=0.9 
-0.20, p=0.3 
 0.14, p=0.5 
 0.13, p=0.5 
 0.11, p=0.6 
-0.02, p=0.9 
 0.28, p=0.2 
 0.16, p=0.5 
 0.15, p=0.5 
-0.01, p=0.9 
 0.16, p=0.5 
-0.40, p=0.04 
-0.40, p=0.04 
-0.35, p=0.08 
-0.38, p=0.06 
FN BMD (g/cm2)  
FN BMD SDS  
FN BMC (g) 
 
-0.05, p=0.8 
-0.23, p=0.2 
-0.01, p=1.0 
-0.12, p=0.5 
-0.27, p=0.2 
-0.07, p=0.7 
-0.11, p=0.6 
-0.20, p=0.3 
-0.17, p=0.4 
-0.17, p= 0.4 
-0.30, p= 0.1 
-0.15, p= 0.5 
 0.04, p=0.8 
-0.14, p=0.5 
 0.05, p=0.8 
-0.02, p=0.9 
-0.21, p=0.3 
 0.03, p=0.9 
-0.44, p=0.03 
  -0.40, p=0.05                       
  -0.43, p=0.03 
App BV/TV 
App TbN  (mm-1) 
-0.30, p=0.1 
 -0.40, p=0.04 
-0.28, p=0.2 
-0.26, p=0.2 
-0.20, p=0.3 
-0.29, p=0.1 
-0.29, p=0.1 
-0.27, p=0.2 
-0.14, p=0.5 
-0.03, p=0.9 
-0.07, p=0.7 
 0.07, p=0.7 
  -0.29, p=0.1 
  -0.28, p=0.2 
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App TbSp (mm) 
App ThTh (mm) 
  0.37, p=0.06 
0.01, p=0.9 
 0.32, p=0.1 
-0.03, p=0.9 
 0.31, p=0.1 
 0.09, p=0.6 
 0.35, p=0.1 
-0.02, p=0.9 
 0.12, p=0.6 
-0.02, p=0.9 
 0.00, p=0.9 
-0.02, p=0.9 
0.36, p=0.1 
  -0.03, p=0.9 
 
 
Table 3 Correlations between measures of bone health and adiposity as assessed by DXA and MRI in the whole cohort of cases of 
T1DM and healthy women. CSA- cross-sectional area of adipose tissue; SCAT – subcutaneous adipose tissue; VAT- visceral adipose tissue; 
TAT – total adipose tissue; TB FM- total body fat mass; TB BMC; total body bone mineral content; TB BMD; total body bone mineral density; 
LS BMC- lumbar spine bone mineral content; LS BMD- lumbar spine bone mineral density; LS BMAD- lumbar spine bone mineral apparent  
density; FN-BMC; femoral neck bone mineral content; FN-BMD; femoral neck bone mineral density; AppBV/TV – apparent bone volume/total 
volume; AppTb.N – apparent trabecular number; AppTbSp – apparent trabecular separation; AppTbTh – apparent trabecular thickness; BMA– 
bone marrow adiposity.  
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